Howard Sklamberg leads the Office of Compliance in its efforts to protect the American public from unsafe and ineffective drug products by ensuring that companies comply with federal standards for quality and safety. Mr. Sklamberg served as the deputy associate commissioner for regulatory affairs in the Office of Regulatory Affairs (ORA) from July 2011 until he joined CDER in January 2013. Prior to that, he was director of ORA's Office of Enforcement. Before coming to FDA, Mr. Sklamberg was a federal prosecutor serving as deputy chief of the Fraud and Public Corruption Section in the United States Attorney’s Office for the District of Columbia, as an assistant U.S. attorney in that office and as a trial attorney in the Justice Department's Public Integrity Section. He specialized in the prosecution of white collar crime, including public corruption, health-care fraud and violations of the Federal Food, Drug and Cosmetic Act. He is an adjunct professor at American University's Washington College of Law, where he teaches courses on congressional investigations and white collar crime. Mr. Sklamberg graduated from Harvard Law School, received a bachelor’s degree in economics and political science from Yale University, and earned a master’s degree from the Fletcher School of Law and Diplomacy.